Related Topics
  Liver Disorders
  Hepatitis C
  Liver Cancer
Site Map
Tell a Friend

Research Predicts Outcomes From Fatty Liver Disease

Certain forms of the illness can lead to cirrhosis, diabetes and increased death

By Robert Preidt
HealthDay Reporter


article logo

WEDNESDAY, Oct. 25 (HealthDay News) -- Patients with a condition called nonalcoholic fatty liver disease (NAFLD) are more likely to develop end-stage liver disease and are more likely to die if they have a form of the illness called nonalcoholic steatohepatitis, Swedish researchers report.

Nonalcoholic steatohepatitis is a form of NAFLD that can lead to cirrhosis.

A team at University Hospital in Linkoping also concluded that most NAFLD patients will eventually develop diabetes or impaired glucose tolerance, which can lead to cardiovascular problems.

The findings were published in the October issue of Hepatology.

"Given the strong association between insulin resistance and NAFLD, it is reasonable to recommend lifestyle modifications in all patients with NAFLD," the study authors wrote. "Not only do lifestyle modifications reduce the risk of developing type 2 diabetes, intense dietary intervention may also improve liver [health] in NAFLD."

NAFLD is one of the most common causes of liver disease in the world. People with NAFLD often have elevated liver enzymes but no symptoms of the disease. Obesity is a major risk factor for NAFLD.

Hepatology, news release, October 2006

Blood Test Index May Help Liver Patients Avoid Biopsy.

Diabetes Drug Helps Prevent Fatty Liver Complications.

Drug Combo Fights Tough-to-Treat Hepatitis C.

Research Predicts Outcomes From Fatty Liver Disease.

Test May Predict Liver Cancer Prognosis.

Last modified 18 September 2006
Questions or comments? Please contact our Webmaster.
About Us, Terms of Use, Privacy Policy, Medical Board
© NCERx group inc. 2007 All rights reserved.